Navigation Links
Rise in Opioid Use for Abdominal Pain Points to Larger Problem Warns Waismann Method Medical Director
Date:12/6/2011

BEVERLY HILLS, Calif., Dec. 6, 2011 /PRNewswire/ -- A new study, released by the American Gastroenterological Association, shows outpatient clinics across the United States witnessed opiate prescriptions for chronic abdominal pain more than double between 1997 and 2008.  Dr. Michael Lowenstein, co-medical director for the Waismann Method, an advanced procedure for rapid opiate detox, warns that this increase signals the gaining popularity of prescription painkillers and its general use to treat any type of pain, regardless of the source or cause.

"Potential side effects of prescription painkillers include gastrointestinal symptoms, like constipation, nausea, vomiting, bloating and cramping, which can lead to more severe abdominal pain," said Dr. Lowenstein.  "The fact that physicians are prescribing opiate medications for persistent abdominal pain indicates that prescription painkillers have become a go-to treatment to instantly satisfy patients' demands, without really understanding if there are advantages of their use. This study indicates physicians may be prescribing opiate painkillers for almost any symptom or condition without fully evaluating the risks and potentially negative consequences for patients."

According to the study, while outpatient visits for chronic abdominal pain decreased between 1997 and 2008 from 14.8 million to 12.2 million visits, opiate prescriptions to treat these patients significantly rose.  Opiates were prescribed for 5.9 percent of chronic abdominal pain cases from 1997 through 1999.  From 2006 through 2008, the number of chronic abdominal pain cases treated with prescription painkillers rose to 12.2 percent.  The study also shows that while opiate prescriptions were l
'/>"/>

SOURCE Waismann Method
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
3. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
4. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
5. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
6. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
7. Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment
8. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
9. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
10. One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials
11. Classwide Opioids REMS: A Good Idea, Implement Carefully
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... BreedIT Ltd., the exclusive worldwide distributor of highly sophisticated ... that on January 7, 2014, the Company,s board of ... Ben-Zion Weiner as its new member of the ...
(Date:1/15/2014)... R.I. , Jan. 15, 2014 MultiCell Technologies, ... filed a U.S. provisional patent application concerning composition of ... to achieve targeted tumor cell death.  ... small noncoding double stranded RNA molecules (VSRNAs) which interfere ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
(Date:4/17/2014)... Diego School of Medicine report that older women, plucky ... loss are more likely to be compassionate toward strangers ... in this month,s issue of the International Journal ... associated with better health and well-being as we age, ... the outcomes of individuals whose deficits in compassion put ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... discovering a new mechanism that allows blood to enter ... Irvine and the Salk Institute have opened the door ... brain damage. , A complex and devastating neurological condition, ... reason for disability in the U.S. The blood-brain barrier ... material into the brain, causing the permanent deficits in ...
(Date:4/17/2014)... Arias, M.D., Ph.D., at The University of Texas Health ... superbug that caused a bloodstream infection in a Brazilian ... of The New England Journal of Medicine . ... of highly-resistant bacteria known as methicillin-resistant Staphylococcus aureus ... hospital and community-associated infections. The superbug has also acquired ...
(Date:4/17/2014)... D.C. -- The world is less than 40 years ... implications for people and governments, according to a top ... the first time in human history, food production will ... of land, water and energy," said Dr. Fred Davies, ... security. "Food issues could become as politically destabilizing by ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:New MRSA superbug emerges in Brazil 2Health News:Food shortages could be most critical world issue by mid-century 2
... , , SAN DIEGO, ... reported financial results for the second quarter of 2009, including non-GAAP ... (STD), clinical diagnostics and total product sales. , , ... as a good performance from our core STD franchise, the inclusion ...
... , WASHINGTON, JULY 30 An estimated 4.1 million ... a House health reform bill, according to state-specific analysis of ... week by The Heritage Foundation . , ... a highly respected health care policy and management consulting firm, to examine ...
... expert says, might help keep elderly out of hospitals ... designed to increase muscle density in the elderly could ... suggests. , The contention stems from a study of ... about a five-year span, more than 55 percent of ...
... , , DALLAS , July ... provider of Internet-based claims processing solutions for the healthcare industry, today reported ... 2009. , , For the quarter ended June ... the $529,000 reported for the second quarter of 2008. Revenues for ...
... , , DALLAS, July 30 When ... Research Institute of Texas (CPRIT), they took a major step forward in ... $3 billion fund investing in cutting-edge, Texas-based research and commercialization projects aimed ... is a privilege for me to be part of CPRIT and to ...
... ... asthma patients to get a swine (H1N1) flu shot in addition to a seasonal flu ... for Disease Control and Prevention,s Vaccine Advisory Committee recommendations July 29 that identified people with ... ...
Cached Medicine News:Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 2Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 3Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 4Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 5Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 6Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 7Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 8Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 9Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 10Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 11Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 12Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 13Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 14Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 15Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 16Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 17Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 18Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 19Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 20Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 21Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 22Health News:Millions of Pennsylvanians Could Lose Private Insurance, Study Shows 2Health News:Muscle Density Linked to Disability 2Health News:Claimsnet.com Reports Second Quarter 2009 Results 2Health News:Claimsnet.com Reports Second Quarter 2009 Results 3Health News:Claimsnet.com Reports Second Quarter 2009 Results 4Health News:Texas on Top of Cancer Research: Dallas Regional Chamber Hosts Forum on New $3 Billion Fund 2Health News:Allergists Urge Asthmatics to Get Swine and Seasonal Flu Shots Following CDC Vaccine Advisory Committee Recommendations 2
XL STABI Hydrophilic Acrylic Lens....
XL OCTO Hydrophilic Acrylic Lens....
One piece multifocal acrylic intraocular lens....
MemoryLens Prefolded Acrylic Lens....
Medicine Products: